Chemcel Bio-tech IPO Subscription Status
Chemcel Bio-tech IPO was subscribed 1.7 times when bidding closed on 12 Sep 2008: NII 1.06x, Retail 2.59x.
The Chemcel Bio-tech IPO has been subscribed 1.7x times overall. Retail investors have shown interest with bids for 2.59x the shares available. The Non-Institutional Investor (NII) category has been subscribed 1.06x. Data last updated on 12 Nov, 08:16 PM.
The IPO subscription period has ended. The issue opened on 09 Sep, 2008 and closes on 12 Sep, 2008. The shares are expected to list on stock exchanges on 13 Oct, 2008.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
Live bidding
Shares bid against shares offered, category by category, as published by the exchanges. Summary splits NII into bHNI (above ₹10 lakh) and sHNI (₹2–10 lakh); switch to Detailed for the exchange's own sub-category rows.
| Category | Bid details | Times |
|---|---|---|
| NII | - of - - | 1.06x |
| Retail | - of - - | 2.59x |
| Employee | - of - - | 0.03x |
| TOTAL | - - | 1.7x |
Chemcel Bio-tech IPO allotment probability
Your odds of an allotment in each category at the current subscription.
Odds = allotment slots ÷ applications, or the subscription multiple where counts aren't available. Retail and HNI allotment is by lottery; QIB is proportionate. Not investment advice.
Subscription insights
What the current book is saying, read off the category numbers above.
Retail Allotment
Subscription is above 1x. While a lottery is guaranteed, your probability of allotment is approximately 38.6% for a single lot.
Day-wise subscription history
End-of-day subscription across the 1-day bidding window. On phones, tap a day for the category split.
| Date | Total | ||
|---|---|---|---|
|
12 Sep 2008
Day 1 |
1.7x | ▼ | |
|
QIB-
BHNI-
SHNI-
Retail2.59x
Employee0.03x
|
|||
Chemcel Bio-tech IPO dates
From the bidding window to listing. Today is 13 November.
- Open 09 Sep 2008
- Close 12 Sep 2008
- Allotment TBA
- Refund/credit TBA
- Listing 13 Oct 2008
What does this subscription data mean?
IPO subscription data tells you how much demand exists for the shares being offered, broken down by investor category. Understanding each category helps you gauge the real sentiment behind the numbers:
- 01 QIB (Qualified Institutional Buyers) — includes mutual funds, FIIs, insurance companies, and banks. QIBs do deep due diligence before bidding. A QIB subscription above 10x is a strong institutional endorsement. Watch QIB numbers closely on the final day — they often hold back and flood in after 3 PM.
- 02 NII / HNI (Non-Institutional Investors) — high-net-worth individuals bidding above ₹2 lakh. NII allotment is proportionate (not lottery), so higher NII subscription means smaller per-lot allotment. Big HNI (B-HNI) bids above ₹10 lakh; Small HNI (S-HNI) bids ₹2–10 lakh.
- 03 Retail — individual investors bidding up to ₹2 lakh. When retail is below 1x, everyone who applied gets full allotment. When oversubscribed, SEBI mandates a computerised lottery — only 1 lot per successful applicant regardless of how many lots you apply for.
- 04 Overall Subscription — a blended multiple across all categories. A total subscription above 10x is considered strong; above 50x is exceptional and usually predicts strong listing gains.
Data sourced from BSE/NSE. Subscription numbers are updated during bidding hours (10 AM – 5 PM IST) on active subscription days.
Frequently asked
What is the current subscription status of Chemcel Bio-tech IPO?
As of IPO close date (12 Sep, 2008), the Chemcel Bio-tech IPO is subscribed 1.7x times. Retail category is 2.59x, and NII is 1.06x subscribed.
When will Chemcel Bio-tech IPO list on the stock market?
Chemcel Bio-tech is scheduled to list on BSE and NSE on 13 October, 2008.
What are the chances of getting allotment in Chemcel Bio-tech IPO?
The retail category is oversubscribed at 2.59x, meaning allotment is by lottery. Statistically, approximately 1 in 3 applicants will receive allotment. Applying with multiple family member accounts (each at minimum lot size) improves your cumulative odds.
Explore Chemcel Bio-tech IPO further
Track every stage of this IPO, from subscription to listing.
It has listed — go back to the fundamentals.
Live grey market premium, Kostak and Subject to Sauda, with the day-wise trend.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
Subscription moves by the hour. Get it on your phone.
Live GMP alerts, subscription updates and allotment status for every Mainboard and SME issue — fast, free and secure.
Not investment advice. Subscription figures are as published by BSE/NSE and change until bidding closes.
